Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 10 de 10
Filtrar
Más filtros












Base de datos
Intervalo de año de publicación
1.
BMC Med Genet ; 19(1): 164, 2018 09 12.
Artículo en Inglés | MEDLINE | ID: mdl-30208859

RESUMEN

BACKGROUND: Multicentric carpotarsal osteolysis syndrome (MCTO) is characterized by progressive destruction and disappearance of the carpal and tarsal bones associated with nephropathy. MCTO is caused by loss-of-function mutations in the MAF bZIP transcription factor B (MAFB) gene. CASE PRESENTATION: This report describes three unrelated patients with MAFB mutations, including two male and one female patient. Osteolytic lesions in the carpal and tarsal bones were detected at 2 years, 12 years, and 14 months of age, respectively. Associated proteinuria was noted at 4 years, 12 years, and 3 months of age, respectively. Kidney biopsy was performed in two of them and revealed focal segmental glomerulosclerosis (FSGS). One patient showed progression to end-stage renal disease, that is by 1 year after the detection of proteinuria. The second patient had persistent proteinuria but maintained normal renal function. In the third patient, who did not undergo a kidney biopsy, the proteinuria disappeared spontaneously. The bony lesions worsened progressively in all three patients. Mutational study of MAFB revealed three different mutations, two novel mutations [c.183C > A (p.Ser61Arg) and c.211C > G (p.Pro71Ala)] and one known mutation [c.212C > T (p.Pro71Leu)]. CONCLUSION: We report three cases with MCTO and two novel MAFB mutations. The renal phenotypes were different among the three patients, whereas progressive worsening of the bony lesions was common in all patients. We also confirmed FSGS to be an early renal pathologic finding in two cases. A diagnosis of MCTO should be considered in patients with progressive bone loss concentrated primarily in the carpal and tarsal bones and kidney involvement, such as proteinuria.


Asunto(s)
Glomeruloesclerosis Focal y Segmentaria/genética , Mutación con Pérdida de Función , Factor de Transcripción MafB/genética , Osteólisis/genética , Proteinuria/genética , Adolescente , Secuencia de Bases , Huesos del Carpo/metabolismo , Huesos del Carpo/patología , Preescolar , Análisis Mutacional de ADN , Progresión de la Enfermedad , Femenino , Expresión Génica , Glomeruloesclerosis Focal y Segmentaria/complicaciones , Glomeruloesclerosis Focal y Segmentaria/metabolismo , Glomeruloesclerosis Focal y Segmentaria/patología , Humanos , Riñón/metabolismo , Riñón/patología , Factor de Transcripción MafB/metabolismo , Masculino , Osteólisis/complicaciones , Osteólisis/metabolismo , Osteólisis/patología , Proteinuria/complicaciones , Proteinuria/metabolismo , Proteinuria/patología , Huesos Tarsianos/metabolismo , Huesos Tarsianos/patología , Adulto Joven
2.
Mil Med ; 182(5): e1814-e1815, 2017 05.
Artículo en Inglés | MEDLINE | ID: mdl-29087931

RESUMEN

Tarsometatarsal osseous coalition is extremely rare. Herein, we present a case of osseous coalition between the base of the third metatarsal and the lateral cuneiform. The patient is a 38-year-old male who presented with an acute episode of foot pain following strenuous activity. Radiographs of the left foot demonstrated an osseous coalition between the third metatarsal base and the lateral cuneiform. Tarsal coalition is a congenital defect that results when adjacent tarsals fail to separate during embryonic development. According to the literature, total osseous coalition is less common than cartilaginous coalition. This case serves as only the second known documented case of osseous coalition between the third metatarsal and the lateral cuneiform, with the first case published in an orthopedic journal. To our knowledge, no case of third metatarsal-lateral cuneiform coalition has been published in the literature otherwise. The intent of this publication is to add to the database of tarsometatarsal coalition cases with a specific emphasis on bony coalition between the third metatarsal and lateral cuneiform.


Asunto(s)
Huesos Metatarsianos/metabolismo , Osteogénesis/fisiología , Dolor/etiología , Huesos Tarsianos/metabolismo , Adulto , Pie/anatomía & histología , Pie/patología , Humanos , Masculino , Radiografía/métodos
3.
J Bone Miner Res ; 31(4): 882-9, 2016 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-26643732

RESUMEN

Growth and differentiation factors (GDFs) are secreted signaling molecules within the BMP family that have critical roles in joint morphogenesis during skeletal development in mice and humans. Using genetic data obtained from a six-generation Chinese family, we identified a missense variant in GDF6 (NP_001001557.1; p.Y444N) that fully segregates with a novel autosomal dominant synostoses (SYNS) phenotype, which we designate as SYNS4. Affected individuals display bilateral wrist and ankle deformities at birth and progressive conductive deafness after age 40 years. We find that the Y444N variant affects a highly conserved residue of GDF6 in a region critical for binding of GDF6 to its receptor(s) and to the BMP antagonist NOG, and show that this mutant GDF6 is a more potent stimulator of the canonical BMP signaling pathway compared with wild-type GDF6. Further, we determine that the enhanced BMP activity exhibited by mutant GDF6 is attributable to resistance to NOG-mediated antagonism. Collectively, our findings indicate that increased BMP signaling owing to a GDF6 gain-of-function mutation is responsible for loss of joint formation and profound functional impairment in patients with SYNS4. More broadly, our study highlights the delicate balance of BMP signaling required for proper joint morphogenesis and reinforces the critical role of BMP signaling in skeletal development.


Asunto(s)
Proteínas Morfogenéticas Óseas , Huesos del Carpo/anomalías , Proteínas Portadoras , Deformidades Congénitas del Pie , Factor 6 de Diferenciación de Crecimiento , Deformidades Congénitas de la Mano , Mutación Missense , Transducción de Señal/genética , Estribo/anomalías , Sinostosis , Huesos Tarsianos/anomalías , Sustitución de Aminoácidos , Animales , Proteínas Morfogenéticas Óseas/genética , Proteínas Morfogenéticas Óseas/metabolismo , Huesos del Carpo/metabolismo , Proteínas Portadoras/genética , Proteínas Portadoras/metabolismo , Línea Celular , Deformidades Congénitas del Pie/genética , Deformidades Congénitas del Pie/metabolismo , Factor 6 de Diferenciación de Crecimiento/genética , Factor 6 de Diferenciación de Crecimiento/metabolismo , Deformidades Congénitas de la Mano/genética , Deformidades Congénitas de la Mano/metabolismo , Humanos , Ratones , Estribo/metabolismo , Sinostosis/genética , Sinostosis/metabolismo , Huesos Tarsianos/metabolismo
4.
J Radiol Case Rep ; 8(6): 27-38, 2014 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-25426232

RESUMEN

An 87 year-old white female presented with a two-year history of intermittent discomfort in her left foot. PET-CT identified intense18F-fluorodeoxyglucose (FDG) uptake corresponding to the lesion. Histology of a fine needle aspiration and open biopsy were consistent with a benign giant cell tumor (GCT) of the bone. GCT of bone is an uncommon primary tumor typically presenting as a benign solitary lesion that arises in the end of the long bones. While GCT can occur throughout the axial and appendicular skeleton, it is exceedingly uncommon in the bone of the foot. While 18F-FDG has been established in detecting several malignant bone tumors, benign disease processes may also be identified. The degree of 18F-FDG activity in a benign GCT may be of an intensity that can be mistakenly interpreted as a malignant lesion. Therefore, GCT of the bone can be included in the differential diagnosis of an intensely 18F-FDG-avid neoplasm located within the tarsal bones.


Asunto(s)
Biopsia con Aguja Fina , Neoplasias Óseas/diagnóstico por imagen , Fluorodesoxiglucosa F18/metabolismo , Tumores de Células Gigantes/diagnóstico por imagen , Tomografía de Emisión de Positrones , Radiofármacos/metabolismo , Huesos Tarsianos/metabolismo , Anciano de 80 o más Años , Neoplasias Óseas/metabolismo , Neoplasias Óseas/patología , Femenino , Tumores de Células Gigantes/metabolismo , Tumores de Células Gigantes/patología , Humanos , Tomografía de Emisión de Positrones/métodos , Huesos Tarsianos/diagnóstico por imagen , Huesos Tarsianos/patología , Tomografía Computarizada por Rayos X , Resultado del Tratamiento
5.
Hum Mutat ; 32(8): 877-86, 2011 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-21538686

RESUMEN

The NOG gene encodes noggin, a secreted polypeptide that is important for regulating multiple signaling pathways during human development, particularly in cartilage and bone. The hallmark of NOG-related syndromes is proximal symphalangism, defined by abnormal fusion of the proximal interphalangeal joints of the hands and feet. Many additional features secondary to NOG mutations are commonly but inconsistently observed, including a characteristic facies with a hemicylindrical nose, congenital conductive hearing loss due to stapes fixation, and hyperopia. The variable clinical presentations led to the designation of five different autosomal dominant syndromes, all subsequently found to have resulted from NOG mutations. These include (1) proximal symphalangism; (2) multiple synostoses syndrome 1; (3) stapes ankylosis with broad thumbs and toes; (4) tarsal-carpal coalition syndrome; and (5) brachydactyly type B2. Herein, we review the phenotypic features associated with mutations in the NOG gene, demonstrating the overlapping characteristics of these syndromes. Due to the variable phenotypic spectrum within families and among families with the same mutation, we propose a unifying term, NOG-related symphalangism spectrum disorder (NOG-SSD), to aid in the clinical recognition and evaluation of all affected individuals with these phenotypes. These NOG gene variants are available in a new locus-specific database (https://NOG.lovd.nl).


Asunto(s)
Braquidactilia/diagnóstico , Proteínas Portadoras/genética , Pérdida Auditiva/diagnóstico , Mutación/genética , Sinostosis/diagnóstico , Braquidactilia/genética , Braquidactilia/metabolismo , Huesos del Carpo/anomalías , Huesos del Carpo/metabolismo , Proteínas Portadoras/metabolismo , Bases de Datos Genéticas , Deformidades Congénitas del Pie/diagnóstico , Deformidades Congénitas del Pie/genética , Deformidades Congénitas del Pie/metabolismo , Deformidades Congénitas de la Mano/diagnóstico , Deformidades Congénitas de la Mano/genética , Deformidades Congénitas de la Mano/metabolismo , Pérdida Auditiva/genética , Pérdida Auditiva/metabolismo , Humanos , Fenotipo , Polimorfismo Genético , Estribo/anomalías , Síndrome , Sinostosis/genética , Sinostosis/metabolismo , Huesos Tarsianos/anomalías , Huesos Tarsianos/metabolismo
6.
J Dent Res ; 88(1): 45-50, 2009 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-19131316

RESUMEN

The human body displays central circadian rhythms of activity. Recent findings suggest that peripheral tissues, such as bone, possess their own circadian clocks. Studies have shown that osteocalcin protein levels oscillate over a 24-hour period, yet the specific skeletal sites involved and its transcriptional profile remain unknown. The current study aimed to test the hypothesis that peripheral circadian mechanisms regulate transcription driven by the osteocalcin promoter. Transgenic mice harboring the human osteocalcin promoter linked to a luciferase reporter gene were used. Mice of both genders and various ages were analyzed non-invasively at sequential times throughout 24-hour periods. Statistical analyses of luminescent signal intensity of osteogenic activity from multiple skeletal sites indicated a periodicity of ~ 24 hrs. The maxillomandibular complex displayed the most robust oscillatory pattern. These findings have implications for dental treatments in orthodontics and maxillofacial surgery, as well as for the mechanisms underlying bone remodeling in the maxillomandibular complex.


Asunto(s)
Ritmo Circadiano/genética , Mandíbula/metabolismo , Maxilar/metabolismo , Osteocalcina/genética , Animales , Huesos del Carpo/anatomía & histología , Huesos del Carpo/metabolismo , Femenino , Regulación de la Expresión Génica/genética , Semivida , Humanos , Procesamiento de Imagen Asistido por Computador/métodos , Luciferasas , Luminiscencia , Masculino , Mandíbula/anatomía & histología , Maxilar/anatomía & histología , Ratones , Ratones Transgénicos , Modelos Animales , Osteogénesis/genética , Regiones Promotoras Genéticas/genética , Factores Sexuales , Cráneo/anatomía & histología , Cráneo/metabolismo , Cola (estructura animal)/anatomía & histología , Cola (estructura animal)/metabolismo , Huesos Tarsianos/anatomía & histología , Huesos Tarsianos/metabolismo , Transcripción Genética/genética
7.
Ann Anat ; 190(5): 452-60, 2008 Nov 20.
Artículo en Inglés | MEDLINE | ID: mdl-18723333

RESUMEN

The size and shape of tarsal bones are especially relevant when considering some orthopedic diseases such as clubfoot. For this reason, the measurements of the tarsal bones have been the subject of many studies, none of which has used stereological methods to estimate the volume. In the present stereological study, we estimated the volume of calcaneal bone of normal feet and dry bones. We used a combination of the Cavalieri principle and computer tomographic scans taken from eight males and nine dry calcanei to estimate the volumes of calcaneal bones. The mean volume of dry calcaneal bones was estimated, producing mean results using the point-counting method and Archimedes principle being 49.11+/-10.7 or 48.22+/-11.92 cm(3), respectively. A positive correlation was found between anthropometric measurements and the volume of calcaneal bones. The findings of the present study using the stereological methods could provide data for the evaluation of normal and pathological volumes of calcaneal bones.


Asunto(s)
Calcáneo/anatomía & histología , Calcáneo/diagnóstico por imagen , Autopsia , Calcáneo/metabolismo , Femenino , Lateralidad Funcional , Humanos , Cinética , Masculino , Tamaño de los Órganos , Caracteres Sexuales , Huesos Tarsianos/anatomía & histología , Huesos Tarsianos/diagnóstico por imagen , Huesos Tarsianos/metabolismo , Tomografía Computarizada por Rayos X/métodos
8.
Bone ; 43(4): 724-33, 2008 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-18619567

RESUMEN

Fatigue fracture of cuboidal bones occurs in the human foot as well as the equine carpus. The racehorse provides a naturally-occurring model to study the effects of high-intensity exercise on the morphology and metabolism of cuboidal bones. We studied both the mineral and the collagenous matrix of the third (C(3)) and radial (C(r)) carpal bones of raced and non-raced Thoroughbred (TB) horses. We hypothesised that racehorses would show increases in the mineral component of these bones and post-translational modifications of the collagenous matrix alongside changes in markers of collagen remodelling and bone formation. C(3) and C(r) carpal bones were retrieved from raced TB horses (n=14) and non-raced TB horses (n=11). Standardised proximal-distal sections were taken from each bone and these were sliced transversely to study the proximal-distal differences in bone metabolism from the subchondral plate through to trabecular bone. Histomorphometry and bone mineral density measurements were performed in parallel with biochemical analyses including total collagen, collagen synthesis and cross-links, matrix metalloproteinases-2 and 9 and their inhibitors, calcium and phosphate, and bone alkaline phosphatase. The results of this study show that, while there is a net increase in bone formation in the racehorses, there is additionally an increase in bone collagen synthesis and remodelling, particularly within the trabecular regions of the bone. The increase in bone density would lead to greater stiffness, particularly in the cortical bone, and failure of this 'stiffer' cortical bone may result from its lack of support from the rapidly remodelling and structurally weakened underlying trabecular bone.


Asunto(s)
Caballos/fisiología , Condicionamiento Físico Animal/fisiología , Huesos Tarsianos/anatomía & histología , Huesos Tarsianos/metabolismo , Fosfatasa Alcalina/metabolismo , Animales , Densidad Ósea , Calcio/metabolismo , Colágeno/metabolismo , Metaloproteinasa 2 de la Matriz/metabolismo , Metaloproteinasa 9 de la Matriz/metabolismo , Modelos Animales , Fosfatos/metabolismo , Huesos Tarsianos/química
9.
J Spinal Cord Med ; 27(3): 207-11, 2004.
Artículo en Inglés | MEDLINE | ID: mdl-15478521

RESUMEN

BACKGROUND/OBJECTIVE: The objective of this study was to document acute bone loss at the os calcis and compare it with bone loss at the knee following spinal cord injury (SCI) as a potential proxy for bone loss in individuals with SCI. METHODS: Bone mineral density (BMD) was measured by dual energy x-ray absorptiometry (DEXA) at the knee and os calcis, which also was assessed by ultrasound in 6 individuals--5 with complete SCI and 1 with incomplete SCI--at means of 33.5 and 523 days following injury. RESULTS: Bone mineral was progressively greater as measured from proximal to distal sites. The net average BMD of the knee declined 24% (P = 0.017). The distal femur lost 27% (P = 0.038) and the proximal tibia lost 32% (P = 0.015), whereas the os calcis lost 38% (P = 0.001) as measured by DEXA and 49% (P < 0.001) as estimated from ultrasound. The mean loss of 24% at the knee was significantly different from the loss percentages at the os calcis as measured by both techniques: DEXA (P = 0.036) and ultrasound (P = 0.043). Differences between annualized loss rates at the knee and the os calcis measured by both techniques also were significant: DEXA (P = 0.032) vs ultrasound (P = 0.038). However, annualized loss rates demonstrated the same trend for differential loss at the sites examined in the 5 individuals with complete injuries but not for the 1 participant with an incomplete injury. The loss rates were similar for the complete and incomplete participants at the os calcis, but not at the knee. CONCLUSION: The BMD of the os calcis declined 38% by DEXA and 49% by ultrasound compared with 24% at the knee when measured 1 to 1.5 years after injury. BMD of the os calcis and distal femur measured by DEXA in persons with complete SCI were highly correlated (r = 0.84, P < 0.0001).


Asunto(s)
Densidad Ósea , Fémur/metabolismo , Osteoporosis/etiología , Traumatismos de la Médula Espinal/complicaciones , Huesos Tarsianos/metabolismo , Tibia/metabolismo , Absorciometría de Fotón , Adulto , Femenino , Fémur/diagnóstico por imagen , Estudios de Seguimiento , Humanos , Masculino , Huesos Tarsianos/diagnóstico por imagen , Tibia/diagnóstico por imagen , Factores de Tiempo , Ultrasonografía
10.
Res Vet Sci ; 75(2): 113-20, 2003 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-12893159

RESUMEN

The study hypothesis was that navicular disease is a process analogous to degenerative joint disease, which leads to changes in navicular fibrocartilage and in deep digital flexor tendon (DDFT) matrix composition and that the process extends to the adjacent distal interphalangeal joint. The objectives were to compare the biochemical composition of the navicular articular and palmar cartilages from 18 horses with navicular disease with 49 horses with no history of front limb lameness, and to compare navicular fibrocartilage with medial meniscus of the stifle and collateral cartilage of the hoof. Cartilage oligomeric matrix protein (COMP), deoxyribonucleic acid (DNA), total glycosaminoglycan (GAG), metalloproteinases MMP-2 and MMP-9 and water content in tissues were measured. Hyaline cartilage had the highest content of COMP and COMP content in hyaline cartilage and tendon was higher in lame horses than in sound horses (p<0.05). The concentration of MMP-2 amount in hyaline cartilage was higher in lame horses than in sound horses. The MMP-2 amounts were significantly higher in tendons compared to other tissue types. Overall, 79% of the lame horses with lesions had MMP-9 in their tendons and the amount was higher than in sound horses (p<0.05). In horses with navicular disease there were matrix changes in navicular hyaline and fibrocartilage as well as the DDFT with potential implications for the pathogenesis and management of the condition.


Asunto(s)
Cartílago/metabolismo , Enfermedades del Pie/veterinaria , Pezuñas y Garras , Enfermedades de los Caballos/metabolismo , Caballos , Artropatías/veterinaria , Animales , Cartílago/patología , Cartílago Articular/metabolismo , Cartílago Articular/patología , ADN/análisis , ADN/metabolismo , Proteínas de la Matriz Extracelular/análisis , Proteínas de la Matriz Extracelular/metabolismo , Femenino , Enfermedades del Pie/metabolismo , Enfermedades del Pie/patología , Miembro Anterior/patología , Glicosaminoglicanos/análisis , Glicosaminoglicanos/metabolismo , Enfermedades de los Caballos/patología , Hialina/metabolismo , Artropatías/metabolismo , Artropatías/patología , Cojera Animal/patología , Masculino , Metaloproteinasa 2 de la Matriz/análisis , Metaloproteinasa 2 de la Matriz/metabolismo , Metaloproteinasa 9 de la Matriz/análisis , Metaloproteinasa 9 de la Matriz/metabolismo , Huesos Tarsianos/metabolismo , Huesos Tarsianos/patología , Tendones/metabolismo , Tendones/patología , Agua/análisis , Agua/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...